Latest News

Intrinsic Imaging Publishes Results of Artificial Intelligence (AI) Pivotal Study in the American Journal of Roentgenology

ISO Certified Intrinsic Imaging Core Lab Completes Very Large 12,480 Read Pivotal Oncology Clinical Trial in 5 Weeks

Leading Artificial Intelligence (AI) Company Selects Intrinsic Imaging to Conduct Pivotal Clinical Trial to Support FDA Submission

Intrinsic Imaging Selected by an Emerging Artificial Intelligence (AI) Company for Pivotal Medical Device Clinical Trial

Intrinsic Imaging Awarded Pivotal Phase II Clinical Trial Focused on Treatment of Degenerative Neuromuscular Disorder

Intrinsic Imaging Awarded Tenth Clinical Trial for Computer Aided Detection (CAD) / Artificial Intelligence (AI) / Deep Learning (DL) Software

Intrinsic Imaging Awarded New Clinical Study to Evaluate Innovative Tumor Imaging Platform

Intrinsic Imaging Awarded a Validation Study for the Development of an Innovative Medical Device to Aid in the Evaluation of Gastrointestinal Motility

Intrinsic Imaging Awarded Another Pivotal Multiple-Reader Multiple-Case (MRMC) Study to Assess the Clinical Performance of CAD Software

Intrinsic Imaging Awarded GIST Clinical Trial for the Treatment of Gastrointestinal Stromal Tumors

Intrinsic Imaging Awarded Phase III Clinical Trial Focused on Brain Metastases of Non-Small Cell Lung Cancer (NSCLC)

Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Intrinsic Imaging Appoints Industry Veteran James Warpula Vice President, Quality Assurance and Compliance

Intrinsic Imaging’s Quality Management System Attains ISO 27001 Informational Security Certification

Vol. 6, Issue 10 : Inferior Vena Cava Filters

Vol. 6, Issue 9 : WHO, RECIST, mRECIST, Cheson, EASL and Novel Biologics

Intrinsic Imaging Appoints Bryan Wayne as Vice President, Imaging Operations

Vol. 6, Issue 8 : Metastatic Colorectal Cancer

Intrinsic Imaging Awarded International Clinical Trial to Determine Efficacy of Innovative Class III Medical Device

Intrinsic Imaging Awarded Large Pivotal Phase III Oncology Trial for Metastatic Breast Cancer

Vol. 6, Issue 7 : Neurological Imaging: Contrast Enhancement in Clinical Trials

Vol. 6, Issue 6 : Tissue Iron Deposition : MRI Quantitation in Clinical Trials

Vol. 6, Issue 5 : Imaging of Rheumatoid Arthritis

Intrinsic Imaging Awarded International Phase II Trial for Arthritis

Vol. 6, Issue 4 : Complex Spinal Deformities: Medical Imaging in Clinical Trials

Clinical Trial Sponsors Agree Intrinsic Imaging Core Lab Provides Exceptional Quality

Vol. 6, Issue 3 : Imaging and Monitoring Tumor Response in Clinical Trials

Intrinsic Imaging’s ISO Certified QMS to be featured at the Imaging in Clinical Trials Event

Intrinsic Imaging Awarded Pivotal Phase III Trial to Assess Novel Oral Chemotherapeutic for Metastatic Breast Cancer

Vol. 5, Issue 9 : Medical Imaging of Osteoarthritis

Vol. 5, Issue 8 : The Challenge of Quantitative Measurements of Primary Brain Tumors

Vol. 5, Issue 11 : Quantitative MRI and Imaging Endpoints in Orthopedic Clinical Trials

Vol. 5, Issue 10 : Chronic Lymphocytic Leukemia

Vol. 5, Issue 7 : Coronary Artery Calcium Scoring

Vol. 5, Issue 6 : Contrast Echocardiographic Imaging in Clinical Trials

Vol. 5, Issue 5 : irRECIST and Immuno-Oncology

Vol. 5, Issue 4 : Temporal Lobe Epilepsy and Volumetric MRI in Clinical Trials

Vol. 5, Issue 3 : Functional Imaging of the Dopamine Pathway

Vol. 5, Issue 2 : Advances in Imaging of Non-Small Cell Lung Cancer (NSCLC)

Vol. 5, Issue 1 : ImmunoTherapy and Imaging of Metastatic Pancreatic Adenocarcinoma

Intrinsic Imaging Awarded Medical Device Trial for Percutaneous Tumor Ablation

Intrinsic Imaging Awarded Phase II Clinical Trial for Glioblastoma Multiforme (GBM)

Vol. 4, Issue 3 : Oncologic Imaging – The Benefits of Diffusion Weighted MRI

Vol. 4, Issue 1 : Magnetic Resonance Elastography – Evaluation of Liver Disease

Intrinsic Imaging Obtains ISO 22301 Business Continuity Management System Certification

Intrinsic Imaging Awarded Phase II Clinical Trial for Treatment of Advanced Squamous Cell Carcinoma (SCC)

Intrinsic Imaging Appoints Ms. Amy Zastawney, RN MPH. as VP, Business Development

Intrinsic Imaging Awarded Interventional Medical Device Trial for Prevention of Pulmonary Emboli

Intrinsic Imaging Reports Exceptional 2014 Customer Satisfaction Survey Results

Vol. 4, Issue 11 : Osteoporosis Imaging

Vol. 4, Issue 10 : Echocardiography : Advantages in Clinical Trials

Vol. 4, Issue 9 : Muscular Dystrophy: Medical Imaging in Clinical Trials

Medical Imaging Consulting Group Expanded at Intrinsic Imaging

Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkins Lymphoma

Intrinsic Imaging Awarded International Phase II Study for Novel Vascular Medical Device

Intrinsic Imaging Awarded Genitourinary Medical Device Clinical Trial

Vol. 4, Issue 8 : The Advances of High Field MRI in the Assessment of Arthritis

Intrinsic Imaging ISO 13485 Medical Device Certification Leads to Award of Lung Cancer Clinical Trial

Vol. 4, Issue 7 : Computed Tomography Data Acquisition in Clinical Trials

Intrinsic Imaging Awarded Landmark Medical Device Trial for Treatment of Symptomatic Venous Outflow Obstruction

Vol. 4, Issue 6 : The Challenges of Reducing Lung Cancer Mortality with Screening

Vol. 4, Issue 5 : Orthopedic Device Assessments : Challenges in Clinical Trials

Intrinsic Imaging Awarded Global Clinical Trial for Hepatocellular Carcinomas

Vol. 4, Issue 4 : Imaging Analysis and Operative Treatment of Diaphyseal Fractures

Intrinsic Imaging Awarded Clinical Study for Novel Neurointerventional Medical Device

Vol. 4, Issue 2 : Screening Mammography CAD

Intrinsic Imaging Obtains ISO 13485 Medical Device Certification

Intrinsic Imaging Core Lab Expertise Contributes to Another FDA Approval

Intrinsic Imaging Awarded Phase II Clinical Trial for Cardiovascular Disease

Intrinsic Imaging Awarded Multi-Center Study for a Novel Vascular Medical Device

Intrinsic Imaging Awarded International Phase II Clinical Trial for Chronic Iron Overload

Metastatic Colorectal Cancer (mCRC) Phase I/II Trial Awarded to Intrinsic Imaging

Intrinsic Imaging Awarded Large 5 Year International Phase II Clinical Trial to Treat Iron Overload

Intrinsic Imaging Opens Medical Imaging Office in Greater Boston

Orthopedic Medical Device Phase III Clinical Trial Awarded to Intrinsic Imaging

Intrinsic Imaging Awarded Large International Phase III Clinical Trial for the Treatment of Severe Traumatic Brain Injury

Intrinsic Imaging Undergoes Extensive FDA Audit – Receives Zero 483 Observations

Intrinsic Imaging Awarded International Phase III Clinical Trial for Cystic Fibrosis

Intrinsic Imaging Awarded Phase II Trial for Metastatic Pancreatic Cancer

Intrinsic Imaging Core Lab Expertise Contributes to FDA Clearance of Medical Device

Intrinsic Imaging Implements ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems

Intrinsic Imaging Awarded Cardiovascular Clinical Trial

Intrinsic Imaging Awarded Important Clinical Trial for the Evaluation of Breast Disease

Neurointerventional Medical Device Clinical Trial Awarded to Intrinsic Imaging

Intrinsic Imaging Awarded Multinational Phase II Trial for the Study of Metastatic Breast Cancer

Metastatic Colorectal Cancer Clinical Trial Awarded to Intrinsic Imaging

Intrinsic Imaging Awarded Pivotal Multi-Center Clinical Trial for Acute Ischemic Stroke

Intrinsic Imaging Appoints Leading Vascular and Interventional Radiologist Dr. Amit Mehta as Vice President and Chief Medical Officer

Intrinsic Imaging Publishes Its Metrics Champion Consortium Imaging Performance Targets

Announcing Intrinsic Imaging – Radiology Experts Launch Novel Medical Imaging Core Lab for Clinical Trials